Menu
Search
|

Menu

Close
X

Endologix Inc ELGX.OQ (NASDAQ Stock Exchange Global Select Market)

4.05 USD
+0.01 (+0.25%)
As of Feb 24
chart
Previous Close 4.05
Open 4.04
Volume 99,954
3m Avg Volume 154,967
Today’s High 4.09
Today’s Low 4.02
52 Week High 7.66
52 Week Low 3.75
Shares Outstanding (mil) 83.43
Market Capitalization (mil) 478.08
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.82 Mean rating from 11 analysts

KEY STATS

Revenue (mm, USD)
FY17
181
FY16
193
FY15
154
EPS (USD)
FY17
-0.797
FY16
-1.923
FY15
-0.745
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
2.51
5.77
Price to Book (MRQ)
vs sector
4.94
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
253.03
16.52
LT Debt to Equity (MRQ)
vs sector
227.92
12.22
Return on Investment (TTM)
vs sector
-23.25
14.43
Return on Equity (TTM)
vs sector
-64.43
16.13

EXECUTIVE LEADERSHIP

Daniel Lemaitre
Chairman of the Board, Since 2017
Salary: --
Bonus: --
John McDermott
Chief Executive Officer, Director, Since 2017
Salary: $572,000.00
Bonus: $578,623.00
Vaseem Mahboob
Chief Financial Officer, Corporate Secretary, Since 2015
Salary: $350,000.00
Bonus: $194,729.00
John Onopchenko
Chief Operating Officer, Since 2017
Salary: --
Bonus: --
Michael Chobotov
Chief Technology Officer, Since 2016
Salary: $207,692.00
Bonus: $136,563.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

2 Musick
IRVINE   CA   92618-1631

Phone: +1949.5957200

Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.

SPONSORED STORIES